semaglutide cause low blood sugar Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, gallbladder disease, dehydration-related acute kidney injury Frontiers | Safety of Semaglutide

15 Bariatric surgery Bariatric surgery is a highly effective treatment for obesity, often leading to more pronounced and sustained weight loss than GLP-1 RAs (mean difference: 22.7 kg, 95% CI 31.4, 14.0) 16 and pharmalogical treatment as a whole (22.1 kg, 95% CI 28.9, 15.2)

Your doctor may need to adjust opioid dosing or explore alternative pain management strategies to ensure safe, effective treatment

While these medications offer profound weight loss results, they have created a new clinical challenge known as "Ozempic Body" or "Ozempic Face", characterized by significant skin laxity and muscle loss due to rapid weight reduction

But thanks to the approval of a Victoza generic by the US Food and Drug Administration (FDA) in December 2024, patients now have access to another generic GLP-1

Telehealth Weight Loss Program Explained Ivim Health operates as an online membership-based telehealth platform that connects intake, clinician visits, and pharmacy coordination for GLP1 medications